Sun Pharma, a renowned drug manufacturer on Monday said that it had received final approval from the USFDA for the new drug application abbreviated as ANDA, which is the generic version of Ganirelix Acetate Injection, 250 mcg/0.5 mL. This version shares its effects with Organon’s Ganirelix Acetate Injection, 250 mcg/0.5 mL, and is a therapeutic […]
Tag: USFDA
Back to Top